Two Sigma Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
8,895
+5,644
+174% +$376K 0.05% 505
2026
Q1
$204K Buy
+3,251
New +$226K 0.02% 1047
2025
Q2
Sell
-5,631
Closed -$385K 1632
2025
Q1
$385K Buy
+5,631
New +$460K 0.06% 465
2024
Q4
Sell
-17,398
Closed -$1.17M 2075
2024
Q3
$1.17M Buy
17,398
+3,030
+21% +$249K 0.02% 797
2024
Q2
$1.63M Buy
+14,368
New +$1.82M 0.02% 813
2023
Q4
Sell
-5,419
Closed -$554K 3153
2023
Q3
$506K Buy
5,419
+3,062
+130% +$345K 0.01% 1534
2023
Q2
$303K Buy
+2,357
New +$285K ﹤0.01% 1862
2022
Q1
Sell
-8,828
Closed -$1.19M 2198
2021
Q4
$1.19M Buy
+8,828
New +$1.27M 0.05% 227
2020
Q4
Sell
-2,136
Closed -$191K 1731
2020
Q3
$220K Buy
+2,136
New +$223K ﹤0.01% 1057

Other funds holding DXCM

Two Sigma Securities's DXCM Position: Q2 2026 in Review

Two Sigma Securities increased its DexCom (DXCM) stake by 174% in Q2 2026, buying an estimated $376K and bringing the position to 8,895 shares worth $599K. The position accounts for 0.05% of the portfolio, ranked #505.

Two Sigma Securities first reported a position in DXCM in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.63M in Q2 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Two Sigma Securities held 8,895 shares of DexCom worth $599K as of Q2 2026.
  • Two Sigma Securities bought 5,644 DexCom shares in Q2 2026, an estimated $376K.
  • DexCom made up 0.05% of Two Sigma Securities's portfolio in Q2 2026, its #505 holding.
  • Two Sigma Securities first reported a position in DexCom in Q3 2020 and has held it in 9 quarters since.
  • Two Sigma Securities's DexCom position peaked at $1.63M in Q2 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.